Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands

Journal of Immunology

Volumn 179, Issue 9, 2007, Pages 5977-5989

  Yu, Junli ^a   Heller, Glenn ^a   Chewning, Joseph ^a   Kim, Sungjin ^b   Yokoyama, Wayne M ^b   Hsu, Katharine C ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B ANTIGEN; HLA C ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; AUTOANTIGEN; CD94 ANTIGEN; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 2; LIGAND; NATURAL KILLER CELL ACTIVATING RECEPTORS; UNCLASSIFIED DRUG;

ARTICLE; CELL FUNCTION; CELL TRANSPLANTATION; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; MOLECULAR CLONING; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; CELL LINE; CLASSIFICATION; GENETICS; IMMUNOLOGY; METABOLISM; SENSITIVITY AND SPECIFICITY;

ANTIGENS, CD94; AUTOANTIGENS; CELL LINE; HLA-B ANTIGENS; HLA-C ANTIGENS; HUMANS; INTERLEUKIN-2; KILLER CELLS, NATURAL; LIGANDS; RECEPTORS, IMMUNOLOGIC; RECEPTORS, KIR; SENSITIVITY AND SPECIFICITY;

EID: 38449091911     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.9.5977     Document Type: Article

References (41)

1. Biron, C. A., K. B. Nguyen, G. C. Pien, L. P. Cousens, and T. P. Salazar-Mather. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17: 189-220.
2. Trinchieri, G. 1989. Biology of natural killer cells. Adv. Immunol. 47: 187-376.
3. Ljunggren, H. G., and K. Karre. 1990. In search of the missing self: MHC molecules and NK recognition. Immunol. Today 11: 237-244.
4. Colonna, M., and J. Samaridis. 1995. Cloning of immunoglobulin- superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 268: 405-408.
5. Long, E. O. 1999. Regulation of immune responses through inhibitory receptors. Annu. Rev. Immunol. 17: 875-904.
6. Lanier, L. 2005. NK cell recognition. Annu. Rev. Immunol. 23: 225-274.
7. Fernandez, N., E. Treiner, R. Vance, A. Jamieson, S. Lemieux, and D. Raulet. 2005. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 105: 4416-4423.
8. Kim, S., J. Poursine-Laurent, S. Truscott, L. Lybarger, Y. Song, L. Yang, A. French, J. Sunwoo, S. Lemieux, T. Hansen, and W. Yokoyama. 2005. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436: 709-713.
9. Anfossi, N., P. Andre, S. Guia, C. Falk, S. Roetnynck, C. Stewart, V. Breso, C. Frassati, D. Reviron, D. Middleton, et al. 2006. Human NK cell education by inhibitory receptors for MHC class I. Immunity 25: 331-342.
10. Hsu, K. C., X. Liu, A. Selvakumar, E. Mickelson, R. J. O'Reilly, and B. Dupont. 2002. Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J. Immunol. 169: 5118-5129.
11. Lee-MacAry, A., E. Ross, D. Davies, R. Laylor, J. Honeychurch, M. Glennie, D. Snary, and R. Wilkinson. 2001. Development of a novel flow cytometric cell-mediated cytotoxicity assay using the fluorophores PKH-26 and TO-PRO-3 iodide. J. Immunol. Methods 252: 83-92.
12. Maxwell, L. D., A. Wallace, D. Middleton, and M. D. Curran. 2002. A common KIR2DS4 deletion variant in the human that predicts a soluble KIR molecule analogous to the KIR1D molecule observed in the rhesus monkey. Tissue Antigens 60: 254-258.
13. Hsu, K., C. Keever-Taylor, A. Wilton, C. Pinto, G. Heller, K. Arkun, R. O'Reilly, M. Horowitz, and B. Dupont. 2005. Improved outcome in allogeneic hematopoietic stem cell transplantation in acute myelogenous leukemia (AML) predicted by donor KIR genotype and recipient HLA genotype in T-cell depleted HLA-identical sibling transplants. Blood 105: 4878-4884.
14. Valiante, N. M., M. Uhrberg, H. G. Shilling, K. Lienert-Weidenbach, K. L. Arnett, A. D'Andrea, J. H. Phillips, L. L. Lanier, and P. Parham. 1997. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 7: 739-751.
15. Raulet, D. H., R. E. Vance, and C. W. McMahon. 2001. Regulation of the natural killer cell receptor repertoire. Annu. Rev. Immunol. 19: 291-330.
16. Cooley, S., F. Xiao, M. Pitt, M. Gleason, V. McCullar, T. Bergemann, K. McQueen, L. Guethlein, P. Parham, and J. Miller. 2007. A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self MHC is developmentally immature. Blood 110: 578-586.
17. Ruggeri, L., M. Capanni, E. Urbani, K. Perruccio, W. D. Shlomchik, A. Tosti, S. Posati, D. Rogaia, F. Frassoni, F. Aversa, et al. 2002. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295: 2097-2100.
18. Giebel, S., F. Locatelli, T. Lamparelli, A. Velardi, S. Davies, G. Frumento, R. Maccario, F. Bonetti, J. Wojnar, M. Martinetti, et al. 2003. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood 102: 814-819.
19. Miller, J., Y. Soignier, A. Panoskaltsis-Mortari, S. McNearney, G. Yun, S. Fautsch, D. McKenna, C. Le, T. Defor, L. Burns, et al. 2005. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood 105: 3051-3057.
20. Pando, M. J., C. M. Gardiner, M. Gleimer, K. L. McQueen, and P. Parham. 2003. The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1. J. Immunol. 171: 6640-6649.
21. Yawata, M., N. Yawata, M. Draghi, A. Little, F. Partheniou, and P. Parham. 2006. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J. Exp. Med. 203: 633-645.
22. VandenBussche, C., S. Dakshanamurthy, P. Posch, and C. Hurley. 2006. A single polymorphism disrupts the killer Ig-like receptor 2DL2/2DL3 D1 domain. J. Immunol. 177: 5347-5357.
23. Shilling, H. G., N. Young, L. A. Guethlein, N. W. Cheng, C. M. Gardiner, D. Tyan, and P. Parham. 2002. Genetic control of human NK cell repertoire. J. Immunol. 169: 239-247.
24. Salmon-Divon, M., P. Hoglund, and R. Mehr. 2003. Generation of the natural killer cell repertoire: the sequential versus the two-step selection model. Bull. Math. Biol. 65: 199-218.
25. Salmon-Divon, M., P. Hoglund, and R. Mehr. 2003. Models for natural killer cell repertoire formation. Clin. Dev. Immunol. 10: 183-192.
26. Salmon-Divon, M., P. Hoglund, M. Johansson, S. Johansson, and R. Mehr. 2005. Computational modeling of human natural killer cell development suggests a selection process regulating coexpression of KIR with CD94/NKG2A. Mol. Immunol. 42: 397-403.
27. +Ly-49- cells: a possible mechanism of tolerance during NK cell development. J. Immunol. 162: 6976-6980.
28. Grzywacz, B., N. Kataria, M. Sikora, R. Oostendorp, E. Dzierzak, B. Blazar, J. Miller, and M. Verneris. 2006. Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells. Blood 108: 3824-3833.
29. Mingari, M., C. Vitale, C. Cantoni, R. Bellomo, M. Ponte, F. Schiavetti, S. Bertone, A. Moretta, and L. Moretta. 1997. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. Eur. J. Immunol. 27: 1374-1380.
30. Shilling, H., D. McQueen, N. Cheng, J. Shizuru, R. Negrin, and P. Parham. 2003. Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation. Blood 101: 3730-3740.
31. Cooley, S., V. McCullar, R. Wangen, T. Bergemann, S. Spellman, D. Weisdorf, and J. Miller. 2005. KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation. Blood 106: 4370-4376.
32. Khakoo, S. I., R. Rajalingam, B. P. Shum, K. Weidenbach, L. Flodin, D. G. Muir, F. Canavez, S. L. Cooper, N. M. Valiante, L. L. Lanier, and P. Parham. 2000. Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans. Immunity 12: 687-698.
33. Shum, B., L. Flodin, D. Muir, R. Rajalingam, S. Khakoo, S. Cleland, L. Guethlein, M. Uhrberg, and P. Parham. 2002. Conservation and variation in human and common chimpanzee CD94 and NKG2 genes. J. Immunol. 168: 240-252.
34. dim NK cells upon activation. J. Immunol. 178: 4947-4955.
35. Gasser, S., and D. Raulet. 2006. Activation and self-tolerance of natural killer cells. Immunol. Rev. 214: 130-142.
36. Doucey, M., L. Scarpellino, J. Zimmer, P. Guillaume, I. F. Luescher, C. Bron, and W. Held. 2004. Cis association of Ly49A with MHC class I restricts natural killer cell inhibition. Nat. Immunol. 5: 328-336.
37. Ruggeri, L., M. Capanni, M. Casucci, I. Volpi, A. Tosti, K. Perruccio, E. Urbani, R. S. Negrin, M. F. Martelli, and A. Velardi. 1999. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood 94: 333-339.
38. Hsu, K., T. Gooley, M. Malkki, C. Pinto-Agnello, B. Dupont, J. Bignon, M. Bornhauser, F. Christiansen, A. Gratwohl, Y. Morishima, et al. 2006. KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy. Biol. Blood Marrow Transplant. 12:828-836.
39. Miller, J., S. Cooley, P. Parham, S. Farag, M. Verneris, K. McQueen, L. Guethlein, E. Trachtenberg, M. Haagenson, M. Horowitz, et al. 2007. Missing KIR-ligands is associated with less relapse and increased graft versus host disease (GVHD) following unrelated donor allogeneic HCT. Blood 109: 5058-5061.
40. Nguyen, S., N. Dhedin, J. Vernant, M. Kuentz, A. Jijakli, N. Rouas-Freiss, E. Carosella, A. Boudifa, P. Debre, and V. Vieillard. 2005. NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect. Blood 105: 4135-4142.
41. Fischer, F., H. Ottinger, S. Ferencik, M. Sribar, M. Punzel, D. Beelen, M. Schwan, H. Grosse-Wilde, P. Wernet, and M. Uhrberg. 2007. Relevance of C1 and C2 epitopes for hemopoietic stem cell transplantation: role for sequential acquisition of HLA-C-specific inhibitory killer Ig-like receptor. J. Immunol. 178: 3918-3923.